Purchase CD Products
Sponsor: TransMedics, Inc Meeting
FDALive Interactive CD Purchasing and Licensing Agreement: Please read before selecting this item
Federal law(Title 17 USC, Sections 501 and 506) provides severe civil and criminal penalties for unauthorized use of this product or service. Reproduction, distribution, redistribution and exhibition of FDALive products or services for other than office use is strictly forbidden. Criminal copyright infringements prosecuted by the Federal Bureau of Investigation, and may constitute a felony with a penalty of five years in prison and possible fines of US $250,000.
The product or service you are about to purchase is licensed to the purchasing organization for private use only, all other use is strictly prohibited, without the permission Of Video On Location, Inc.
All Rights Reserved. Copyright 1989-2020, Video On Location, Inc.
Upcoming Meetings
Recent Meetings
Cellular, Tissue, and Gene Therapies AdComm
Meeting Date: 4/15/21-4/15/21
Meeting Details:
The Committee will meet in open session to discuss biologics license application (BLA) 125734 for donislecel (purified allogeneic deceased donor pancreas derived Islets of Langerhans). The applicant, CellTrans, Inc., has requested an indication for the “treatment of brittle Type 1 diabetes mellitus (T1D).” The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.
| Location: | Please note that due to the impact of this COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform. | Related News Links: | Not Available |
| Time: | 10:00AM-6:00PM | ||
| Materials: | |||
- Circulatory System Devices Panel of the MDAC
Sponsor: TransMedics, Inc
Meeting Date: 4/6/21-4/6/21
Meeting Details:
The committee will discuss, make recommendations, and vote on information regarding the premarket approval application for the TransMedics Organ Care System (OCS) Heart, by TransMedics, Inc. The proposed Indication for Use for the TransMedics OCS Heart, is as follows: The TransMedics Organ Care System (OCS) Heart System is a portable extracorporeal heart perfusion and monitoring system indicated for the resuscitation, preservation, and assessment of donor hearts in a near-physiologic, normothermic, and beating state intended for a potential transplant recipient. The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.
| Location: | The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. | Related News Links: | Not Available |
| Time: | 9:00AM-6:00PM | ||
| Materials: | |||
- Joint Meeting of the Arthritis Advisory Committee and the DSaRM
Meeting Date: 3/24/21-3/25/21
Meeting Details:
The committees will discuss biologics license application (BLA) 761130, tanezumab subcutaneous injection, submitted by Pfizer Inc., for the proposed indication of relief of signs and symptoms of moderate to severe osteoarthritis in adult patients for whom use of other analgesics is ineffective or not appropriate. The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.
| Location: | Please note that due to the impact of this COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform. | Related News Links: | Not Available |
| Time: | 9:00AM-4:30PM | ||
| Materials: | |||
- General and Plastic Surgery Devices Panel of the MDAC
Meeting Date: 3/23/21-3/23/21
Meeting Details:
The committee will discuss and make recommendations regarding the benefits and risks of dermal fillers concerning the following topics: (1) risks associated with intravascular injection of dermal fillers and (2) patient preference and informed decision making. FDA is convening this meeting to seek expert opinion on the clinical evaluation and regulation of dermal filler products. The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.
| Location: | Please note that due to the impact of this COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform. | Related News Links: | Not Available |
| Time: | 9:00AM-6:00PM | ||
| Materials: | |||
Sign in to FDALive
My Shopping Cart
FDA
FDA
About FDALive